Literature DB >> 19921360

Presynaptic M1, M2, and A1 receptors play roles in tetanic fade induced by pancuronium or cisatracurium.

Elaine Campana Sanches Bornia1, Erika Bando, Miguel Machinski, Monalisa Wolski Pereira, Wilson Alves-Do-Prado.   

Abstract

PURPOSE: We investigated whether presynaptic facilitatory M1 and/or inhibitory M2 muscarinic receptors contributed to pancuronium- and cisatracurium-induced tetanic fade.
METHODS: Phrenic nerve-diaphragm muscle preparations of rats were indirectly stimulated with tetanic frequency (75 +/- 3.3 Hz; mean +/- SD). Doses of pancuronium, cisatracurium, hexamethonium, and d-tubocurarine for producing approximately 25% fade were determined. The effects of pirenzepine and methoctramine, blockers of presynaptic M1 and M2 receptors, respectively, on the tetanic fade were investigated.
RESULTS: The concentrations required for approximately 25% fade were 413 microM for hexamethonium (26.8 +/- 2.4% 4% fade), 55 nM for d-tubocurarine (28.7 +/- 2.55% fade), 0.32 microM for pancuronium (25.4 +/- 2.2% fade), and 0.32 microM for cisatracurium (24.7 +/- 0.8% fade). Pirenzepine or methoctramine alone did not produce the fade. Methoctramine, 1 microM, attenuated the fade induced by hexamethonium (to 16.0 +/- 2.5% fade), d-tubocurarine (to 6.0 +/- 1.6 fade), pancuronium (to 8.0 +/- 4.0% fade), and cisatracurium (to 11.0 +/- 3.3% fade). 10 nM pirenzepine attenuated only the fades produced by pancuronium (to 5.0 +/- 0.11% fade) and cisatracurium (to 13.3 +/- 5.3% fade). Cisatracurium (0.32 microM) showed antiacetylcholinesterase activity (in plasma, 14.2 +/- 1.6%; 6%; in erythrocyt 17.2 +/- 2.66%) similar to that of pancuronium (0.32 microM). The selective A1 receptor blocker, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 2.5 nM), also attenuated the fades induced by pancuronium and cisatracurium.
CONCLUSION: The tetanic fades produced by pancuronium and cisatracurium depend on the activation of presynaptic inhibitory M2 receptors; these agents also have anticholinesterase activities. The fades induced by these agents also depend on the activation of presynaptic inhibitory A1 receptors through the activation of stimulatory M1 receptors by acetylcholine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921360     DOI: 10.1007/s00540-009-0790-z

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  12 in total

1.  Observations on the isolated phrenic nerve diaphragm preparation of the rat.

Authors:  E BULBRING
Journal:  Br J Pharmacol Chemother       Date:  1946-03

Review 2.  Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors.

Authors:  I Wessler
Journal:  Trends Pharmacol Sci       Date:  1989-03       Impact factor: 14.819

3.  Reversal by atropine of tetanic fade induced in cats by antinicotinic and anticholinesterase agents.

Authors:  W Alves-do-Prado; A P Corrado; W A Prado
Journal:  Anesth Analg       Date:  1987-06       Impact factor: 5.108

Review 4.  Quantal acetylcholine release at the vertebrate neuromuscular junction.

Authors:  W Van der Kloot; J Molgó
Journal:  Physiol Rev       Date:  1994-10       Impact factor: 37.312

5.  Neuromuscular facilitation induced by muscarinic antagonists in the rat isolated diaphragm.

Authors:  W Alves-do-Prado; W A Prado
Journal:  Gen Pharmacol       Date:  1993-11

Review 6.  Prejunctional and postjunctional cholinoceptors at the neuromuscular junction.

Authors:  W C Bowman
Journal:  Anesth Analg       Date:  1980-12       Impact factor: 5.108

7.  The neuromuscular transmission fade (Wedensky inhibition) induced by L-arginine in neuromuscular preparations from rats.

Authors:  H M Silva; C R Ambiel; W Alves-Do-Prado
Journal:  Gen Pharmacol       Date:  1999-06

8.  Inhibition of human plasma cholinesterase and erythrocyte acetylcholinesterase by nondepolarizing neuromuscular blocking agents.

Authors:  M Kato; Y Hashimoto; T Horinouchi; T Ando; J Ito; H Yamanaka
Journal:  J Anesth       Date:  2000-01-20       Impact factor: 2.078

9.  Blockade of neuronal facilitatory nicotinic receptors containing alpha 3 beta 2 subunits contribute to tetanic fade in the rat isolated diaphragm.

Authors:  Miguel Faria; Laura Oliveira; M Alexandrina Timóteo; M Graça Lobo; Paulo Correia-De-Sá
Journal:  Synapse       Date:  2003-08       Impact factor: 2.562

10.  Modulation by adenosine of both muscarinic M1-facilitation and M2-inhibition of [3H]-acetylcholine release from the rat motor nerve terminals.

Authors:  Laura Oliveira; M Alexandrina Timóteo; Paulo Correia-de-Sá
Journal:  Eur J Neurosci       Date:  2002-06       Impact factor: 3.386

View more
  4 in total

1.  Effects of presynaptic muscarinic cholinoreceptor blockade on neuromuscular transmission as assessed by the train-of-four and the tetanic fade response to rocuronium.

Authors:  Yong Beom Kim; Sangseok Lee; Kyeong Chun Lee; Ha Jung Kim; Young Jin Ro; Hong-Seuk Yang
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-07       Impact factor: 2.557

2.  Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant.

Authors:  Irina V Shelukhina; Maxim N Zhmak; Alexander V Lobanov; Igor A Ivanov; Alexandra I Garifulina; Irina N Kravchenko; Ekaterina A Rasskazova; Margarita A Salmova; Elena A Tukhovskaya; Vladimir A Rykov; Gulsara A Slashcheva; Natalya S Egorova; Inessa S Muzyka; Victor I Tsetlin; Yuri N Utkin
Journal:  Toxins (Basel)       Date:  2018-01-07       Impact factor: 4.546

3.  Effects of neuromuscular presynaptic muscarinic M1 receptor blockade on rocuronium-induced neuromuscular blockade in immobilized tibialis anterior muscles.

Authors:  Yong Beom Kim; Hong-Seuk Yang; Ha Jung Kim; Hey-Ran Choi; Junyong In; Soon-Young Yoon; Young Jin Ro
Journal:  Clin Exp Pharmacol Physiol       Date:  2018-08-30       Impact factor: 2.557

4.  Effects of adenosine receptor agonist on the rocuroniuminduced neuromuscular block and sugammadex-induced recovery.

Authors:  Yong Beom Kim; Sangseok Lee; Hey Ran Choi; Junyong In; Young Jin Chang; Ha Jung Kim; Young Jin Ro; Hong-Seuk Yang
Journal:  Korean J Anesthesiol       Date:  2018-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.